Atypical femoral fracture risk in patients treated with bisphosphonates.
Department of Medicine, University of California, San Francisco, CA 94107, USA. dbauer@psg.ucsf.edu
Douglas C
DC
Bauer
D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D005264:Femoral Fractures / Q000000981:diagnostic imaging* / Q000453:epidemiology*; D006801:Humans; D008297:Male; D011859:Radiography
D050071:Bone Density Conservation Agents; D004164:Diphosphonates